J. Rusnak

发表

Health Care Response to CCHF in US Soldier and Nosocomial Transmission to Health Care Providers, Germany, 2009

S. Günther, N. Conger, M. Kortepeter, 2015, Emerging infectious diseases.

Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.

J. Rusnak, N. Machesky, E. H. Moore, 2019, Toxicon : official journal of the International Society on Toxinology.

Botulinum Toxin Chapter 16 BOTULINUM TOXIN

Leonard A. Smith, Z. Dembek, J. Rusnak, 2008 .

Experience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses

J. Rusnak, 2011 .

Botulinum Neurotoxins from Clostridium botulinum

Leonard A. Smith, J. Rusnak, 2014 .

Botulinum Neurotoxin Vaccines: Past history and recent developments

Leonard A. Smith, J. Rusnak, 2009, Human vaccines.

A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.

C. Schmaljohn, J. Rusnak, J. Hooper, 2012, Vaccine.

Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.

J. Rusnak, P. Pittman, P. Gibbs, 2011, Vaccine.

An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study).

R. Gibbons, I. Clements, J. Martin, 2001, The American journal of cardiology.

Laboratory Exposures to Staphylococcal Enterotoxin B

M. Kortepeter, J. Rusnak, M. Poli, 2004, Emerging infectious diseases.

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea☆

T. Cosgriff, J. Huggins, J. Rusnak, 2008, Antiviral Research.

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit

M. Kortepeter, J. Rusnak, Kelly L. Warfield, 2008, Emerging infectious diseases.

History of U.S. military contributions to the study of parasitic diseases.

N. Aronson, J. Rusnak, J. Cross, 2005, Military medicine.

Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities

Leonard A. Smith, Z. Dembek, J. Rusnak, 2007, Disaster Medicine and Public Health Preparedness.

False-positive rapid plasma reagin tests in human immunodeficiency virus infection and relationship to anti-cardiolipin antibody and serum immunoglobulin levels.

C. Butzin, J. Rusnak, S. Blatt, 1994, The Journal of infectious diseases.

Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers.

M. Kortepeter, R. Hawley, E. Eitzen, 2004, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

J. Rusnak, L. Ward, L. Dupuy, 2018, Comparative medicine.

Botulinum neurotoxin vaccines: past, present, and future.

Leonard A. Smith, J. Rusnak, 2007, Critical reviews in immunology.

Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule

S. Weaver, Pamela J. Glass, C. Sabourin, 2019, Viruses.

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.

J. Eldridge, Susan E. Witko, D. Clarke, 2020, The Lancet. Infectious diseases.

In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients

R. Paxton, H. Kessler, G. Shearer, 1997, Clinical and diagnostic laboratory immunology.

Toxicity of bilirubin to Leishmania tropica promastigotes.

M. W. Simon, J. Rusnak, A. J. Mukkada, 1976, Experimental parasitology.

Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons.

W. Mccarthy, R. Hensley, W. Ward, 1995, The Journal of infectious diseases.

TCRBV CDR3 diversity of CD4+ and CD8+ T-lymphocytes in HIV-infected individuals.

R. Schelonka, J. Teale, J. Rusnak, 2002, Human immunology.

Longitudinal phase 2 clinical trials of live, attenuated tularemia vaccine in otherwise healthy research laboratory workers operating in containment laboratories

M. Kortepeter, J. Rusnak, B. Purcell, 2023, medRxiv.

Chapter 21 Medical Countermeasures Introduction Bacterial and Rickettsial Diseases Anthrax Tularemia Plague Glanders and Melioidosis Brucellosis Q Fever Virology Alphaviruses Smallpox Viral Hemorrhagic Fevers

S. Bavari, J. Rusnak, M. Hepburn, 2009 .

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

L. Jagodzinski, A. Esber, I. Jani, 2021, Open Forum Infectious Diseases.

Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individuals.

J. Rusnak, D. Tribble, K. Wagner, 1997, AIDS.

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

A. Sher, M. Clerici, H. Kessler, 1996, The Journal of infectious diseases.

HIV-1 infection induces a selective reduction in STAT5 protein expression.

M. Dolan, G. Shearer, R. Kirken, 1998, Journal of immunology.

Reduction in STAT5 Protein Expression Cutting Edge: HIV-1 Infection Induces a Selective

M. Dolan, R. Kirken, F. Pericle, 1997 .

Chapter 31 – Botulism Vaccines and the Immune Response

Leonard A. Smith, J. Rusnak, 2009 .

Management Guidelines for Laboratory Exposures to Agents of Bioterrorism

M. Kortepeter, R. Hawley, J. Rusnak, 2004, Journal of occupational and environmental medicine.

Antigen‐stimulated apoptotic T‐cell death in HIV infection is selective for CD4+T cells, modulated by cytokines and effected by lymphotoxin

J. Berzofsky, R. Coffman, M. Clerici, 1996, AIDS.

Experience in the Medical Management of Potential Laboratory Exposures to Agents of Bioterrorism on the Basis of Risk Assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)

M. Kortepeter, J. Rusnak, E. Boudreau, 2004, Journal of occupational and environmental medicine.